Press Releases Cellectis S.A.

Equities

ALCLS

FR0010425595

Market Closed - Euronext Paris Other stock markets 09:05:19 02/05/2024 pm IST			After market 01:04:33 am
2.6 ^EUR	+6.78%		2.725	+4.81%

05:30pm	European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	MT
29/04	Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cellectis Appoints Arthur Stril as Interim Chief Financial Officer	02:00am	GL
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023	30/04	GL
Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	23/04	AQ
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	23/04	GL
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs	11/04	GL
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting	09/04	GL
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social	05/04	PU
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social	05/03	PU
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	22/02	AQ
Cellectis announces the drawdown of the second tranche of EUR15 million under the credit facility agreement entered with the European Investment Bank	17/01	AQ
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)	17/01	GL
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)	17/01	AQ
Cellectis S A : Vote Results General Shareholders’ Meeting December 22, 2023	24/12	PU
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023	23/12	GL
Cellectis S A : Extraordinary Resolutions - Form 6-K	23/12	PU
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12	AQ
Cellectis S A : Depositary's Notice of Combined Ordinary and Extraordinary General Meeting of Cellectis S.A - Form 6-K	06/12	PU
Cellectis Shareholders Meeting to be Held on December 22, 2023	20/11	AQ
Cellectis’ Shareholders Meeting to be Held on December 22, 2023	18/11	GL
Cellectis’ Shareholders Meeting to be Held on December 22, 2023	18/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cellectis S.A.

Equities

ALCLS

FR0010425595

Press Releases

Filters